Published in Drug Law Weekly, June 29th, 2004
CMS Administrator Mark B. McClellan, MD, PhD, and NCI Director Andrew C. von Eschenback, MD, said collaborations being developed also will seek to increase the body of information that clinicians and patients use to guide decisions about how new technologies can be used more effectively to improve the lives of cancer patients.
"With so many new therapeutic options available to patients and doctors, and with patients becoming more active in their medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2004-06-29)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.